57 results
Page 2 of 3
425
6k73puwj5phc7xw1kemg
5 May 21
Business combination disclosure
5:26pm
425
onfp9o2nv5u
5 May 21
Business combination disclosure
5:24pm
6-K
EX-99.5
hpe18o8l
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
twgxbyy0ghfp2gmp
5 May 21
Agreement and Plan of Merger
5:19pm
6-K
EX-99.1
qtivn6
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
70i24v
30 Apr 21
Annual report (foreign)
12:53pm
20-F
EX-2.7
vw53u
30 Apr 21
Annual report (foreign)
12:53pm
424B3
sj4hccvs4 tj
4 Mar 21
Prospectus supplement
8:38am
6-K
EX-99.1
azjhjbq514wmwog zaxp
4 Mar 21
Amryt Announces Record FY 2020 Results
8:20am
424B4
6kf5q2ozcx
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
k3iuucu
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
3nyt x8dvmb
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
jqg 03msh
18 Dec 20
Draft registration statement
12:00am
6-K
s8dp c8ze
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
k8l945g2v9v8znayh7t4
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.1
y1pe 7ihhdy
8 Dec 20
Amryt Announces $40m Private Placement with Leading Biotech Investors
6:05am
6-K
EX-99.1
t3yf 0xcp
3 Nov 20
Current report (foreign)
8:45am
424B4
gxxso5 v6mu6a
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
41d32gqyim
7 Jul 20
Registration statement (foreign) (amended)
5:02pm
F-1/A
vn2rmkr19iu1b
6 Jul 20
Registration statement (foreign) (amended)
5:28pm